Ticker > IPO > newlisted

IPO

Supriya Lifescience Ltd.

One of the key Indian manufacturers and suppliers of active pharmaceuticals ingredients (“APIs”), with a focus on research and development. As of October 31, 2021, the company has niche product offerings of 38 APIs focused on diverse therapeutic segments such as antihistamine, analgesic, anaesthetic, vitamin, anti-asthmatic and antiallergic.

RHP
View
DRHP
View
Open Date

2021-12-16

Close Date

2021-12-20

IPO Details

Check out the issue details for Supriya Lifescience Ltd. IPO as disclosed in SEBI.

IPO Price

₹ 274

Price Band

₹ 265 - 274

Issue Size

700 Cr.

Issue Type

Book Built

Open

2021-12-16

Close

2021-12-20

Listingprice

₹ 421

ListingGain

53.65%

Listing Date

2021-12-28

CMP

₹ 466.85

Current Return

70.38%

Company Financials

You can get the following financial statements of Supriya Lifescience Ltd. as of now.

Subscription Details

The details about the Supriya LifeSciences IPO is as:

  • The issue size of the IPO is 700 Cr.
  • The price band ranges from Rs 265 to Rs 274.
  • The shares of Supriya LifeSciences ltd will list on 28th December 2021.
  • The latest tentative GMP of Supriya LifeSciences IPO is Rs 150.
  • The shares of Supriya LifeSciences is subscribed 71.51 Times as of 20th December 2021.

 

Supriya LifeSciences IPO Valuation

The approx valuation of Supriya LifeSciences IPO based on its price band and DRHP/RHP is:

Particulars Value
Upper Price Band Rs 274
Existing Shares (Qty) 7.31 Cr
Fresh Issue 200  Cr
Market Cap 2202.94 Cr
EPS (FY21) Rs 16.92
PE Ratio 16.19x
Industry PE 23.02x

 

Supriya LifeSciences IPO Issue Size

Supriya LifeSciences IPO issue size is 700 Cr.

Issue Amount
Fresh Issue 200 Cr
Offer For Sale 500 Cr

 

Supriya LifeSciences IPO Market Lot

An Individual can apply for a minimum 1 lot of 54 shares and a maximum of 13 lots of 702 shares. Find the details below:

Application Lot Shares Amount
 Minimum  1 54 Rs 14,796
 Maximum 13 702 Rs 1,92,348

 

Supriya LifeSciences IPO Share Offer

The shares of Supriya LifeSciences is subscribed 71.51 Times as of 20th December 2021. The category-wise share subscription is as follows:

Category % Offered Subscription
Qualified Institutional Minimum 75% 31.83 Times
Non-Institutional Maximum 15% 161.22 Times
Retail Individual Maximum 10% 56.01 Times
Total   71.51 Times

 

Supriya LifeSciences IPO Grey Market Premium

As on GMP (Tentative)
17 December 2021 Rs 280
18 December 2021 Rs 280
19 December 2021 Rs 180
20 December 2021 Rs 180
21 December 2021 Rs 150

It is purely for informational purposes and invest in an IPO after thoroughly researching on your own.

 

Allotment Details

Find below the dates for Supriya LifeSciences IPO:

Schedule Date
Basis of Allotment 23 December 2021
Refunds 24 December 2021
Credit to Demat Account 27 December 2021
IPO Listing Date 28 December 2021

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021
Net Sales 183.5 212.91 277.84 311.64 385.37
Total Expenditure 166.38 190.96 213.41 213.26 218.07
Operating Profit 17.13 21.96 64.43 98.38 167.3
Other Income 7.45 8.59 8.33 11.07 10.86
Interest 11.76 10.75 10.22 6.85 4.08
Depreciation 4.75 5.33 5.44 6.38 6.68
Exceptional Items 0 0 0 0 0
Profit Before Tax 8.06 14.46 57.1 96.23 167.39
Provision for Tax 2.4 5.74 17.68 22.82 43.57
Net Profit 5.66 8.73 39.42 73.4 123.83
Adjusted EPS (Rs.) 0.39 0.6 2.69 5.01 1.69

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021
Equity and Liabilities
Share Capital 14.64 14.64 14.64 14.64 14.64
Total Reserves 31.25 40.02 79.15 134.56 254.31
Borrowings 45.41 35.33 8.14 2.39 0
Other N/C liabilities 5.9 9.53 16.22 29.46 30.86
Current liabilities 144.15 145.88 134.91 155.39 146.02
Total Liabilities 241.34 245.39 253.05 336.43 445.83
Assets
Net Block 88.78 91.01 84.68 97.99 100.15
Capital WIP 35.58 34.38 35.35 40.21 78.79
Intangible WIP 0 0 0 0 0
Investments 0.1 0.12 0.05 0.05 0.05
Loans & Advances 1.84 0.32 0.3 0.18 0.43
Other N/C Assets 0 0 0 0 0
Current Assets 115.04 119.57 132.66 197.99 266.4
Total Assets 241.34 245.39 253.05 336.43 445.83
* Other Non-current Liabilities include Net deferred Liabilities

Quarterly Result (All Figures in Cr.)

PARTICULARS Dec 2021
Other Income 5.44
Profit Before Tax 40.07
Tax 0.43
Profit After Tax 39.64
Adjusted EPS (Rs) 4.93

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021
Profit from operations 8.06 14.46 57.1 96.23 167.39
Adjustment 16.47 15.78 12.67 10.24 5.31
Changes in Assets & Liabilities 2.87 0.8 -6.8 36.6 -62.78
Tax Paid -0.1 -3.29 -14.09 -27.01 -29.99
Operating Cash Flow 27.3 27.75 48.88 116.06 79.93
Investing Cash Flow -26.61 -4.71 4.83 -24.53 -47.41
Financing Cash Flow -2.21 -20.01 -49.93 -29.23 -14.93
Net Cash Flow -1.51 3.03 3.79 62.31 17.59
X